Protein & Cell >

2022 , Vol. 13 >Issue 5: 379 - 385

DOI: https://doi.org/10.1007/s13238-021-00861-8

LETTERS

Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome

  • Yu-Sheng Chen 1,2,4 ,
  • Shuaiyao Lu 3 ,
  • Bing Zhang 1,2 ,
  • Tingfu Du 3 ,
  • Wen-Jie Li 1,2 ,
  • Meng Lei 1,2 ,
  • Yanan Zhou 3 ,
  • Yong Zhang 3 ,
  • Penghui Liu 3 ,
  • Yong-Qiao Sun 1,2 ,
  • Yong-Liang Zhao 1,2,5 ,
  • Ying Yang , 1,2,4,5 ,
  • Xiaozhong Peng , 3,6 ,
  • Yun-Gui Yang , 1,2,4,5
Expand
  • 1. CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, College of Future Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China
  • 2. China National Center for Bioinformation, Beijing 100101, China
  • 3. National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650031, China
  • 4. Institute of Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China
  • 5. University of Chinese Academy of Sciences, Beijing 100049, China
  • 6. State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Medical Primate Research Center, Neuroscience Center, Chinese Academy of Medical Sciences, School of Basic Medicine Peking, Union Medical College, Beijing 100005, China

Published date: 15 May 2022

Copyright

2021 The Author(s)
Fold

Cite this article

Yu-Sheng Chen , Shuaiyao Lu , Bing Zhang , Tingfu Du , Wen-Jie Li , Meng Lei , Yanan Zhou , Yong Zhang , Penghui Liu , Yong-Qiao Sun , Yong-Liang Zhao , Ying Yang , Xiaozhong Peng , Yun-Gui Yang . Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome[J]. Protein & Cell, 2022 , 13(5) : 379 -385 . DOI: 10.1007/s13238-021-00861-8

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Baltimore D(1971) Expression of animal virus genomes. Bacteriol Rev 35:235–241

DOI

2
Geis FK, Goff SP(2020) Silencing and transcriptional regulation of endogenous retroviruses: an overview. Viruses. https://doi.org/10.3390/v12080884

DOI

3
Grandgenett DP, Aihara H(2018) Oligomerization of Retrovirus Integrases. Subcell Biochem 88:211–243

DOI

4
Horie M, Tomonaga K(2011) Non-retroviral fossils in vertebrate genomes. Viruses 3:1836–1848

DOI

5
Smits N, Rasmussen J, Bodea GO, Amarilla AA, Gerdes P, Sanchez-Luque FJ, Ajjikuttira P, Modhiran N, Liang B, Faivre J(2021) No evidence of human genome integration of SARSCoV-2 found by long-read DNA sequencing. Cell Rep. https://doi.org/10.1016/j.celrep.2021.109530

DOI

6
Sultana T, Zamborlini A, Cristofari G, Lesage P(2017) Integration site selection by retroviruses and transposable elements in eukaryotes. Nat Rev Genet 18:292–308

DOI

7
V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V(2021) Coronavirus biology and replication: implications for SARSCoV-2. Nat Rev Microbiol 19:155–170

DOI

8
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z(2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 21:39–51

DOI

9
Yan B, Chakravorty S, Mirabelli C, Wang L, Trujillo-Ochoa JL, Chauss D, Kumar D, Lionakis MS, Olson MR, Wobus CE(2021) Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual. J Virol. https://doi.org/10.1128/JVI.00294-21

DOI

10
Yin Y, Liu XZ, He X, Zhou LQ(2021) Exogenous coronavirus interacts with endogenous retrotransposon in human cells. Front Cell Infect Microbiol 11:

DOI

11
Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R(2021) Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci USA 118:

DOI

12
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X(2020a) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062

DOI

13
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL(2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273

DOI

14
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ(2020a) Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, doubleblind, placebo-controlled, phase 2 trial. Lancet 396:479–488

DOI

15
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R(2020b) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733

DOI

Options
Outlines

/

〈 〉